These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


971 related items for PubMed ID: 16546838

  • 1. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
    Bayorh MA, Mann G, Walton M, Eatman D.
    Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
    [Abstract] [Full Text] [Related]

  • 2. Synergistic actions of enalapril and tempol during chronic angiotensin II-induced hypertension.
    Elmarakby AA, Williams JM, Imig JD, Pollock JS, Pollock DM.
    Vascul Pharmacol; 2007 Feb; 46(2):144-51. PubMed ID: 17112788
    [Abstract] [Full Text] [Related]

  • 3. Mineralocorticoid receptor activation contributes to salt-induced hypertension and renal injury in prepubertal Dahl salt-sensitive rats.
    Kawarazaki H, Ando K, Nagae A, Fujita M, Matsui H, Fujita T.
    Nephrol Dial Transplant; 2010 Sep; 25(9):2879-89. PubMed ID: 20466668
    [Abstract] [Full Text] [Related]

  • 4. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y, Zhu A, Yoneda T, Usukura M, Takata H, Yamagishi M.
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [Abstract] [Full Text] [Related]

  • 5. Simvastatin and losartan enhance nitric oxide and reduce oxidative stress in salt-induced hypertension.
    Bayorh MA, Ganafa AA, Eatman D, Walton M, Feuerstein GZ.
    Am J Hypertens; 2005 Nov; 18(11):1496-502. PubMed ID: 16280288
    [Abstract] [Full Text] [Related]

  • 6. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
    Chung S, Park CW, Shin SJ, Lim JH, Chung HW, Youn DY, Kim HW, Kim BS, Lee JH, Kim GH, Chang YS.
    Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
    [Abstract] [Full Text] [Related]

  • 7. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
    Wang H, Shimosawa T, Matsui H, Kaneko T, Ogura S, Uetake Y, Takenaka K, Yatomi Y, Fujita T.
    J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
    [Abstract] [Full Text] [Related]

  • 8. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
    Onozato ML, Tojo A, Kobayashi N, Goto A, Matsuoka H, Fujita T.
    Nephrol Dial Transplant; 2007 May; 22(5):1314-22. PubMed ID: 17324946
    [Abstract] [Full Text] [Related]

  • 9. Alterations in aldosterone and angiotensin II levels in salt-induced hypertension.
    Bayorh MA, Ganafa AA, Emmett N, Socci RR, Eatman D, Fridie IL.
    Clin Exp Hypertens; 2005 May; 27(4):355-67. PubMed ID: 15921072
    [Abstract] [Full Text] [Related]

  • 10. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.
    Pitt B, Reichek N, Willenbrock R, Zannad F, Phillips RA, Roniker B, Kleiman J, Krause S, Burns D, Williams GH.
    Circulation; 2003 Oct 14; 108(15):1831-8. PubMed ID: 14517164
    [Abstract] [Full Text] [Related]

  • 11. Effect of eplerenone, enalapril and their combination treatment on diabetic nephropathy in type II diabetic rats.
    Kang YS, Ko GJ, Lee MH, Song HK, Han SY, Han KH, Kim HK, Han JY, Cha DR.
    Nephrol Dial Transplant; 2009 Jan 14; 24(1):73-84. PubMed ID: 18682491
    [Abstract] [Full Text] [Related]

  • 12. L-arginine or tempol supplementation improves renal and cardiovascular function in rats with reduced renal mass and chronic high salt intake.
    Carlström M, Brown RD, Yang T, Hezel M, Larsson E, Scheffer PG, Teerlink T, Lundberg JO, Persson AE.
    Acta Physiol (Oxf); 2013 Apr 14; 207(4):732-41. PubMed ID: 23387940
    [Abstract] [Full Text] [Related]

  • 13. Eplerenone potentiates protective effects of amlodipine against cardiovascular injury in salt-sensitive hypertensive rats.
    Nakamura T, Fukuda M, Kataoka K, Nako H, Tokutomi Y, Dong YF, Yamamoto E, Yasuda O, Ogawa H, Kim-Mitsuyama S.
    Hypertens Res; 2011 Jul 14; 34(7):817-24. PubMed ID: 21471977
    [Abstract] [Full Text] [Related]

  • 14. Involvement of oxidative stress in the profibrotic action of aldosterone. Interaction wtih the renin-angiotension system.
    Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL.
    Am J Hypertens; 2004 Jul 14; 17(7):597-603. PubMed ID: 15243979
    [Abstract] [Full Text] [Related]

  • 15. Addition of eplerenone to an angiotensin-converting enzyme inhibitor effectively improves nitric oxide bioavailability.
    Imanishi T, Ikejima H, Tsujioka H, Kuroi A, Kobayashi K, Muragaki Y, Mochizuki S, Goto M, Yoshida K, Akasaka T.
    Hypertension; 2008 Mar 14; 51(3):734-41. PubMed ID: 18227404
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
    Hirono Y, Yoshimoto T, Suzuki N, Sugiyama T, Sakurada M, Takai S, Kobayashi N, Shichiri M, Hirata Y.
    Endocrinology; 2007 Apr 14; 148(4):1688-96. PubMed ID: 17218415
    [Abstract] [Full Text] [Related]

  • 17. Effects of eplerenone, a selective mineralocorticoid receptor antagonist, on clinical and experimental salt-sensitive hypertension.
    Takeda Y.
    Hypertens Res; 2009 May 14; 32(5):321-4. PubMed ID: 19300447
    [Abstract] [Full Text] [Related]

  • 18. Antioxidant enzymes and effects of tempol on the development of hypertension induced by nitric oxide inhibition.
    Sainz J, Wangensteen R, Rodríguez Gómez I, Moreno JM, Chamorro V, Osuna A, Bueno P, Vargas F.
    Am J Hypertens; 2005 Jun 14; 18(6):871-7. PubMed ID: 15925750
    [Abstract] [Full Text] [Related]

  • 19. Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.
    Brand S, Amann K, Mandel P, Zimnol A, Schupp N.
    PLoS One; 2014 Jun 14; 9(12):e115715. PubMed ID: 25551569
    [Abstract] [Full Text] [Related]

  • 20. Chronic antioxidant therapy lowers blood pressure in adult but not in young Dahl salt hypertensive rats: the role of sympathetic nervous system.
    Vaněčková I, Vokurková M, Rauchová H, Dobešová Z, Pecháňová O, Kuneš J, Vorlíček J, Zicha J.
    Acta Physiol (Oxf); 2013 Aug 14; 208(4):340-9. PubMed ID: 23480535
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 49.